Markus P. Kummer, PhD

2003-2006 Neuroscience University of California, San Diego, La Jolla, CA 
 2006-2008 Neurology University of Munster, Münster, Nordrhein-Westfalen, Germany 
 2008-2017 Neurology University of Bonn, Bonn, Nordrhein-Westfalen, Germany 
 2017- Neuroscience AbbVie 
"Markus Kummer"
Mean distance: 18.83 (cluster 31)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Herrera-Rivero M, Santarelli F, Brosseron F, et al. (2019) Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression. Molecular Neurobiology
Rammes G, Seeser F, Mattusch K, et al. (2018) The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP). Neuropharmacology
Brosseron F, Traschütz A, Widmann CN, et al. (2018) Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 25
Venegas C, Kumar S, Franklin BS, et al. (2017) Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease. Nature. 552: 355-361
Traschütz A, Kummer MP, Schwartz S, et al. (2017) Variability and temporal dynamics of novel object recognition in aging male C57BL/6 mice. Behavioural Processes
Wijasa TS, Sylvester M, Brocke-Ahmadinejad N, et al. (2017) Proteome profiling of s-nitrosylated synaptosomal proteins by isobaric mass tags. Journal of Neuroscience Methods
Hong GS, Schwandt T, Stein K, et al. (2015) Effects of macrophage-dependent peroxisome proliferator-activated receptor γ signalling on adhesion formation after abdominal surgery in an experimental model. The British Journal of Surgery
Heneka MT, Carson MJ, El Khoury J, et al. (2015) Neuroinflammation in Alzheimer's disease. The Lancet. Neurology. 14: 388-405
Krauthausen M, Kummer MP, Zimmermann J, et al. (2015) CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model. The Journal of Clinical Investigation. 125: 365-78
Kummer MP, Schwarzenberger R, Sayah-Jeanne S, et al. (2015) Pan-PPAR modulation effectively protects APP/PS1 mice from amyloid deposition and cognitive deficits. Molecular Neurobiology. 51: 661-71
See more...